Verastem, Inc. ( VSTM) - Stock Earnings
VSTM Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
VSTM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -32.9 million USD | 17.5 million USD |
| 2026Q1 | -36.6 million USD | 18.7 million USD |
| 2026Q2 | -34.7 million USD | 40.1 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
VSTM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -87.4 million USD | — USD |
| 2024 | -130.6 million USD | 10.0 million USD |
| 2025 | -209.5 million USD | 30.9 million USD |
| 2026 Est. | — | — |
VSTM
Price: $8.65
52 week price:
Earnings Per Share: -2.40 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 245000
Ebitda: -22.9 millionMarket Capitalization: 676.6 million